<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6083E7FB-0220-4F5F-97B0-7F6113B49A0C"><gtr:id>6083E7FB-0220-4F5F-97B0-7F6113B49A0C</gtr:id><gtr:name>MRC Unit, The Gambia</gtr:name><gtr:address><gtr:line1>MRC Laboratories, The Gambia</gtr:line1><gtr:line2>Atlantic Road PO Box 273</gtr:line2><gtr:line4>Fajara</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Gambia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/79360A65-8FC4-477A-86BC-DAFF9A2BD215"><gtr:id>79360A65-8FC4-477A-86BC-DAFF9A2BD215</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Walther</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U190088486"><gtr:id>0339B9AE-A286-4524-897A-7251D76100DD</gtr:id><gtr:title>Investigating the potential role of Heme Oxygenase 1 in P. falciparum malaria</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U190088486</gtr:grantReference><gtr:abstractText>In a number of diseases the enzyme hemoxygenase 1 (HO-1) has been identified as an important molecule modulating immune responses. Here at the MRC we are studying malaria-induced immuno-regulation and how it relates to disease outcome. To this end, we have set up a case control study comparing the immune responses of children with severe and uncomplicated malaria.||In addition to our ongoing studies of immunoregulation in this cohort, we have compared the level of HO-1 in children with severe and uncomplicated malaria and determined the major cellular source of this enzyme. Data are currently being analysed further. If we find this molecule to be associated with disease outcome in one way or another, there would be the potential to derive therapeutic use of these findings, since drugs licensed for human use are available to either induce or limit the expression of HO-1.</gtr:abstractText><gtr:technicalSummary>In order to promote parasite clearance without inducing immunopathology malaria-induced immune effector mechanisms need to be tightly regulated.||Work in murine malaria models has demonstrated a protective role for the enzyme hemoxigenase 1 (HO-1) in the pathogenesis of severe malaria. To study the role of HO-1 with regard to disease outcome in P.falciparum patients, we have enrolled 274 Gambian children with severe malaria (cases) or uncomplicated malaria (controls) into a study for detailed immunological and molecular analysis, using 9 colour flow-cytometry, RT-PCR, HO-1 ELISA, detection of free heme and Western blot for HO-1 detection.||Data are currently being analysed.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1176978</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>London School of Hygiene and Tropical Medicine (LSHTM)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Infectious and Tropical Diseases</gtr:department><gtr:description>HO-1 in malaria bacterial coinfections</gtr:description><gtr:id>A9BD2994-7DF4-47C3-B500-90D518B88AD0</gtr:id><gtr:impact>Aubrey Cunnington helped complete the first phase of this project by providing an assay to measure intensity of the oxidative burst. This part of the work is written up and currently under review.
Aubrey Cunnington currently continues to study the effect of malaria induced HO-1 on the body's defence against bacterial co-infections.</gtr:impact><gtr:outcomeId>YSgC6m5Ksfv-1</gtr:outcomeId><gtr:partnerContribution>Dr Aubrey Cunnington, an MRC clinical research training fellow came to the Gambia in June 2010 to contribute to the work of the HO-1 project.</gtr:partnerContribution><gtr:piContribution>provision of research platform, provision of assay design (HO-1 RT PCR, HO-1 flowcytometry, PhD supervision of Aubrey Cunnington, provision of study platform for sample recruitment, provision of molecular assays for bacterial coinfection detection</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BD57F176-3BE1-4C13-A098-85DCB54E7D0F</gtr:id><gtr:title>Prolonged neutrophil dysfunction after Plasmodium falciparum malaria is related to hemolysis and heme oxygenase-1 induction.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b74fb834b1126e5527514c363533f630"><gtr:id>b74fb834b1126e5527514c363533f630</gtr:id><gtr:otherNames>Cunnington AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>pm_13797_27_23100518</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5F74B99-2D5B-4D09-8603-17ABF662BBCC</gtr:id><gtr:title>HMOX1 gene promoter alleles and high HO-1 levels are associated with severe malaria in Gambian children.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9220bd722f843e0dac27ddc9068ac50c"><gtr:id>9220bd722f843e0dac27ddc9068ac50c</gtr:id><gtr:otherNames>Walther M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_13797_27_22438807</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U190088486</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>